This 16-week placebo-control study looks to investigate whether patients with schizophrenia
for two years or less may benefit from omega-3 supplements.
Phase:
N/A
Details
Lead Sponsor:
Delbert Robinson
Collaborators:
National Alliance for Research on Schizophrenia and Depression National Institute of Mental Health (NIMH)